Skip to main content

Table 2 Sedation-related adverse events (SRAEs) and subclinical respiratory depression

From: Supraglottic jet oxygenation and ventilation improves oxygenation during endoscopic retrograde cholangiopancreatography: a randomized controlled clinical trial

 

Group N(I)

(n = 56)

Group W(II)

(n = 56)

Group WS(III)

(n = 55)

P-value

(I vs. II)

P-value

(II vs. III)

P-value

(I vs. III)

Subclinical respiratory depression[n(%)]

15(27)

12(21)

3(6)

0.508

0.014

0.002

SRAEs[n(%)]

16(29)

12(21)

2(4)

0.383

0.005

0.000

Hypoxemia

12(21)

11(20)

2(4)

0.815

0.009

0.005

Severe hypoxemia

4(7)

1(2)

0(0)

0.364

1.000

0.118

PETCO2<10mmHg[n(%)]

-

13(23)

4(7)

-

0.020

-

Jaw lift[n(%)]

13(23)

11(20)

2(4)

0.645

0.009

0.003

Mask ventilation[n(%)]

5(9)

5(9)

0(0)

1.000

0.057

0.057

Endotracheal intubation[n(%)]

2(4)

0(0)

0(0)

0.495

-

0.495

  1. Subclinical respiratory depression: SpO2 = 90–95%, SRAEs: SpO2 < 90% and the implementation of emergency measures; PETCO2: End-tidal carbon dioxide partial pressure. The χ2 test and Fisher’s exact test were used to analyze the incidence rate of SRAEs. The P-value was adjusted to 0.05/3 ≈ 0.017 by Bonferroni adjustment